Article info

Download PDFPDF
Extended report
Optimal methotrexate dose is associated with better clinical outcomes than non-optimal dose in daily practice: results from the ESPOIR early arthritis cohort

Authors

  1. Correspondence to Professor Cécile Gaujoux-Viala, Service de Rhumatologie, CHU de Nîmes Carémeau, Place du Professeur Robert Debré, 30029 Nîmes cedex 9, France; cecile.gaujoux.viala{at}chu-nimes.fr
View Full Text

Citation

Gaujoux-Viala C, Rincheval N, Dougados M, et al
Optimal methotrexate dose is associated with better clinical outcomes than non-optimal dose in daily practice: results from the ESPOIR early arthritis cohort

Publication history

  • Received February 6, 2017
  • Revised July 17, 2017
  • Accepted July 31, 2017
  • First published September 2, 2017.
Online issue publication 
November 13, 2017

Article Versions

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.